nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—Benzyl alcohol—CYP2B6—malignant glioma	0.0391	0.248	CrCbGaD
Tolazoline—Phentermine—SLC6A3—malignant glioma	0.0345	0.219	CrCbGaD
Tolazoline—Dextroamphetamine—SLC6A3—malignant glioma	0.0329	0.209	CrCbGaD
Tolazoline—Amphetamine—SLC6A3—malignant glioma	0.0265	0.168	CrCbGaD
Tolazoline—Methamphetamine—SLC6A3—malignant glioma	0.0246	0.156	CrCbGaD
Tolazoline—ADRA2C—Signaling Pathways—FGFR1—malignant glioma	0.000292	0.000347	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PDGFRA—malignant glioma	0.000291	0.000346	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	0.000291	0.000345	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HIF1A—malignant glioma	0.000288	0.000342	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	0.000288	0.000342	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	0.000286	0.00034	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—AKT1—malignant glioma	0.000286	0.000339	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTK2—malignant glioma	0.000284	0.000337	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—PIK3CA—malignant glioma	0.000284	0.000337	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—F2—malignant glioma	0.000284	0.000337	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—FN1—malignant glioma	0.000284	0.000337	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SPP1—malignant glioma	0.000283	0.000336	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCL8—malignant glioma	0.000283	0.000336	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCL8—malignant glioma	0.000282	0.000334	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—BAD—malignant glioma	0.00028	0.000333	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HES1—malignant glioma	0.000279	0.000331	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CAV1—malignant glioma	0.000279	0.000331	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOTCH1—malignant glioma	0.000278	0.00033	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SPP1—malignant glioma	0.000278	0.00033	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NCOR1—malignant glioma	0.000278	0.000329	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	0.000276	0.000328	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—VEGFA—malignant glioma	0.000276	0.000328	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—KDR—malignant glioma	0.000275	0.000327	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TP53—malignant glioma	0.000275	0.000326	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—RAF1—malignant glioma	0.000274	0.000325	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—STAT3—malignant glioma	0.000273	0.000325	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CD80—malignant glioma	0.000272	0.000323	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—APC—malignant glioma	0.000272	0.000322	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CG—malignant glioma	0.000272	0.000322	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CAV1—malignant glioma	0.000271	0.000321	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—IL2—malignant glioma	0.00027	0.000321	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL2—malignant glioma	0.000269	0.00032	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGF—malignant glioma	0.000268	0.000319	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TERT—malignant glioma	0.000268	0.000318	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CB—malignant glioma	0.000267	0.000317	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PTPN11—malignant glioma	0.000267	0.000317	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CD—malignant glioma	0.000267	0.000317	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PDGFRA—malignant glioma	0.000266	0.000316	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—F2—malignant glioma	0.000265	0.000315	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FN1—malignant glioma	0.000265	0.000315	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL2—malignant glioma	0.000264	0.000314	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TERT—malignant glioma	0.000263	0.000312	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—BAD—malignant glioma	0.000262	0.000311	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PDGFB—malignant glioma	0.000262	0.000311	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FGFR1—malignant glioma	0.00026	0.000309	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOTCH1—malignant glioma	0.000259	0.000308	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SPP1—malignant glioma	0.000258	0.000306	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	0.000257	0.000305	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCL8—malignant glioma	0.000257	0.000305	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HIF1A—malignant glioma	0.000257	0.000305	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	0.000256	0.000303	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—BRAF—malignant glioma	0.000255	0.000303	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CD80—malignant glioma	0.000254	0.000302	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MYC—malignant glioma	0.000254	0.000302	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APC—malignant glioma	0.000254	0.000301	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CG—malignant glioma	0.000254	0.000301	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	0.000252	0.000299	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGF—malignant glioma	0.000251	0.000298	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PTPN11—malignant glioma	0.000249	0.000296	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EGFR—malignant glioma	0.000249	0.000295	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT2—malignant glioma	0.000249	0.000295	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CAV1—malignant glioma	0.000248	0.000295	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EGFR—malignant glioma	0.000247	0.000294	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CG—malignant glioma	0.000246	0.000293	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL2—malignant glioma	0.000245	0.000291	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KDR—malignant glioma	0.000245	0.000291	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TERT—malignant glioma	0.000245	0.00029	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CAV1—malignant glioma	0.000243	0.000289	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KDR—malignant glioma	0.000241	0.000286	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CD—malignant glioma	0.000239	0.000283	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	0.000239	0.000283	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—BRAF—malignant glioma	0.000238	0.000283	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PPARG—malignant glioma	0.000238	0.000282	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	0.000237	0.000282	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—PIK3CA—malignant glioma	0.000236	0.000281	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FN1—malignant glioma	0.000236	0.00028	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—F2—malignant glioma	0.000236	0.00028	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—KRAS—malignant glioma	0.000235	0.000279	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	0.000234	0.000278	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—KRAS—malignant glioma	0.000234	0.000278	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—BAD—malignant glioma	0.000233	0.000277	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CB—malignant glioma	0.000232	0.000276	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT2—malignant glioma	0.000232	0.000276	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—AKT1—malignant glioma	0.000232	0.000275	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—F2—malignant glioma	0.000232	0.000275	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FN1—malignant glioma	0.000232	0.000275	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EGFR—malignant glioma	0.000231	0.000274	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOTCH1—malignant glioma	0.000231	0.000274	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—malignant glioma	0.00023	0.000273	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—BAD—malignant glioma	0.000229	0.000272	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—FGF2—malignant glioma	0.000229	0.000271	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	0.000227	0.000269	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CD80—malignant glioma	0.000226	0.000269	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CAV1—malignant glioma	0.000226	0.000269	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APC—malignant glioma	0.000226	0.000268	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CG—malignant glioma	0.000226	0.000268	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KDR—malignant glioma	0.000224	0.000266	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGF—malignant glioma	0.000223	0.000265	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CD—malignant glioma	0.000223	0.000265	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CD80—malignant glioma	0.000222	0.000264	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PTPN11—malignant glioma	0.000222	0.000264	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APC—malignant glioma	0.000222	0.000263	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	0.000222	0.000263	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—PIK3CA—malignant glioma	0.000221	0.000262	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGF—malignant glioma	0.000219	0.00026	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—KRAS—malignant glioma	0.000218	0.000259	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	0.000218	0.000259	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CD—malignant glioma	0.000217	0.000257	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PIK3CA—malignant glioma	0.000216	0.000256	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—F2—malignant glioma	0.000215	0.000256	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FN1—malignant glioma	0.000215	0.000256	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	0.000215	0.000255	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MDM2—malignant glioma	0.000214	0.000254	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—FGF2—malignant glioma	0.000214	0.000254	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RAF1—malignant glioma	0.000213	0.000253	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—BAD—malignant glioma	0.000213	0.000253	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—BRAF—malignant glioma	0.000212	0.000252	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	0.000211	0.00025	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	0.000211	0.00025	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TP53—malignant glioma	0.000209	0.000248	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—BRAF—malignant glioma	0.000208	0.000247	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	0.000208	0.000247	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT2—malignant glioma	0.000207	0.000245	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CD80—malignant glioma	0.000206	0.000245	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APC—malignant glioma	0.000206	0.000245	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	0.000206	0.000245	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EGFR—malignant glioma	0.000206	0.000244	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGF—malignant glioma	0.000204	0.000242	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT2—malignant glioma	0.000203	0.000241	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	0.000202	0.00024	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	0.000202	0.00024	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTEN—malignant glioma	0.000201	0.000238	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	0.000201	0.000238	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	0.0002	0.000237	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MDM2—malignant glioma	0.0002	0.000237	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RAF1—malignant glioma	0.000199	0.000236	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CD—malignant glioma	0.000199	0.000236	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	0.000197	0.000234	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000197	0.000234	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	0.000195	0.000231	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—KRAS—malignant glioma	0.000195	0.000231	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	0.000194	0.000231	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—BRAF—malignant glioma	0.000194	0.00023	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	0.000193	0.000229	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000193	0.000229	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CASP3—malignant glioma	0.000191	0.000227	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL2—malignant glioma	0.000191	0.000227	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	0.000191	0.000227	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—FGF2—malignant glioma	0.00019	0.000226	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CB—malignant glioma	0.000189	0.000224	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT2—malignant glioma	0.000189	0.000224	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	0.000188	0.000223	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—malignant glioma	0.000187	0.000222	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	0.000187	0.000222	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FGF2—malignant glioma	0.000187	0.000222	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	0.000181	0.000215	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MMP9—malignant glioma	0.000181	0.000215	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	0.00018	0.000214	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PTEN—malignant glioma	0.00018	0.000213	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000179	0.000213	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CASP3—malignant glioma	0.000179	0.000212	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	0.000179	0.000212	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL2—malignant glioma	0.000179	0.000212	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MDM2—malignant glioma	0.000178	0.000211	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RAF1—malignant glioma	0.000177	0.000211	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	0.000177	0.000211	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AKT1—malignant glioma	0.000176	0.000209	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ERBB2—malignant glioma	0.000175	0.000208	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	0.000175	0.000208	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	0.000175	0.000208	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MDM2—malignant glioma	0.000175	0.000207	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RAF1—malignant glioma	0.000174	0.000207	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FGF2—malignant glioma	0.000173	0.000206	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CB—malignant glioma	0.000173	0.000206	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	0.000172	0.000204	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	0.00017	0.000202	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MMP9—malignant glioma	0.000169	0.000201	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PTEN—malignant glioma	0.000168	0.000199	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL8—malignant glioma	0.000166	0.000198	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	0.000164	0.000195	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	0.000163	0.000194	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTEN—malignant glioma	0.000163	0.000194	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	0.000163	0.000193	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	0.000162	0.000193	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MDM2—malignant glioma	0.000162	0.000193	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RAF1—malignant glioma	0.000162	0.000192	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—STAT3—malignant glioma	0.000161	0.000191	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AKT1—malignant glioma	0.000161	0.000191	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	0.00016	0.00019	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CASP3—malignant glioma	0.000159	0.000189	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL2—malignant glioma	0.000159	0.000189	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	0.000158	0.000187	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	0.000158	0.000187	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CASP3—malignant glioma	0.000156	0.000186	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL2—malignant glioma	0.000156	0.000185	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	0.000152	0.00018	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	0.000152	0.00018	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MMP9—malignant glioma	0.000151	0.000179	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—STAT3—malignant glioma	0.00015	0.000178	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PTEN—malignant glioma	0.00015	0.000178	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MYC—malignant glioma	0.000149	0.000177	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MMP9—malignant glioma	0.000148	0.000175	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PTEN—malignant glioma	0.000147	0.000174	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	0.000147	0.000174	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGFR—malignant glioma	0.000146	0.000174	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AKT1—malignant glioma	0.000146	0.000173	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CASP3—malignant glioma	0.000145	0.000172	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL2—malignant glioma	0.000145	0.000172	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	0.000143	0.00017	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CA—malignant glioma	0.000142	0.000168	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MYC—malignant glioma	0.00014	0.000166	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—KRAS—malignant glioma	0.000138	0.000164	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MMP9—malignant glioma	0.000137	0.000163	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGFR—malignant glioma	0.000137	0.000162	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTEN—malignant glioma	0.000136	0.000162	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VEGFA—malignant glioma	0.000135	0.00016	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—STAT3—malignant glioma	0.000134	0.000159	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	0.000133	0.000158	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	0.000133	0.000157	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—STAT3—malignant glioma	0.000131	0.000156	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—KRAS—malignant glioma	0.000129	0.000153	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	0.000127	0.000151	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MYC—malignant glioma	0.000124	0.000148	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	0.000123	0.000146	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TP53—malignant glioma	0.000123	0.000146	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MYC—malignant glioma	0.000122	0.000145	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—STAT3—malignant glioma	0.000122	0.000145	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGFR—malignant glioma	0.000122	0.000144	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGFR—malignant glioma	0.000119	0.000142	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	0.000119	0.000141	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AKT1—malignant glioma	0.000116	0.000137	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CA—malignant glioma	0.000115	0.000137	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KRAS—malignant glioma	0.000115	0.000136	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TP53—malignant glioma	0.000115	0.000136	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MYC—malignant glioma	0.000113	0.000135	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KRAS—malignant glioma	0.000113	0.000134	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGFR—malignant glioma	0.000111	0.000132	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CA—malignant glioma	0.000106	0.000125	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KRAS—malignant glioma	0.000105	0.000124	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT1—malignant glioma	0.000104	0.000123	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	0.000104	0.000123	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TP53—malignant glioma	0.000102	0.000121	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TP53—malignant glioma	0.0001	0.000119	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT1—malignant glioma	9.68e-05	0.000115	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	9.63e-05	0.000114	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AKT1—malignant glioma	9.4e-05	0.000112	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TP53—malignant glioma	9.31e-05	0.000111	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT1—malignant glioma	8.62e-05	0.000102	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT1—malignant glioma	8.46e-05	0.0001	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT1—malignant glioma	7.86e-05	9.33e-05	CbGpPWpGaD
